https://carrerasresearch.org/en/publications/smarca4-deficient-tumours-are-vulnerable-to-kdm6autx-and-kdm6bjmjd3-blockade/
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade